Qiagen NV reported $78.3M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
argenx SE USD 719M 164.73M Jun/2026
Avita Medical AUD 8.96M 1.69M Dec/2025
Dianthus Therapeutics USD 6.39M 1.12M Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
IQVIA Holdings USD 3.61B 31M Jun/2026
Moderna USD 167M 6M Jun/2026
Organon & Co USD 983M 31M Mar/2026
Qiagen NV USD 78.3M 5.64M Mar/2026
Revvity USD 165.74M 3.94M Jun/2026
Tectonic Therapeutic USD 2.55M 1.46M Mar/2026
Viatris USD 1.24B 40.6M Jun/2026
Xeris Pharmaceuticals USD 9.34M 2.13M Jun/2026